(Q40642180)

22 September 2017

title

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. (English)

1 reference

22 September 2017

0 references

1

Dirk Grimm

1 reference

22 September 2017

Mark A Kay

2

1 reference

22 September 2017

Juergen A Kleinschmidt

series ordinal

3

1 reference

22 September 2017

publication date

1 June 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

7

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

839-850

1 reference

Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Novel tools for production and purification of recombinant adenoassociated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

The cryptic life style of adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

Subcellular compartmentalization of adeno-associated virus type 2 assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900095-9

7 January 2021

10.1016/S1525-0016(03)00095-9

Identifiers

DOI

1 reference

22 September 2017

1 reference